Location History:
- Chapel Hill, NC (US) (2008 - 2022)
- Hillsborough, NC (US) (2017 - 2023)
Company Filing History:
Years Active: 2008-2023
Title: Ken Phares: Innovator in Pharmaceutical Patents
Introduction
Ken Phares is a notable inventor based in Chapel Hill, NC (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, Phares has made substantial advancements in drug formulations and delivery methods.
Latest Patents
Among his latest patents, Phares has developed novel prodrugs of treprostinil, which include methods of making and using these prodrugs. Additionally, he has created compounds and methods for the delivery of prostacyclin analogs. This invention focuses on prostacyclin formulations and their applications in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, and providing cytoprotection, among other benefits.
Career Highlights
Phares has built a distinguished career at United Therapeutics Corporation, where he has been instrumental in advancing innovative therapies. His work has not only contributed to the company's success but has also had a lasting impact on the pharmaceutical industry.
Collaborations
Throughout his career, Phares has collaborated with esteemed colleagues, including David Mottola and Roger Jeffs. These partnerships have fostered a collaborative environment that encourages innovation and the development of groundbreaking therapies.
Conclusion
Ken Phares stands out as a prominent inventor in the pharmaceutical sector, with a strong portfolio of patents that reflect his dedication to improving healthcare through innovative drug delivery systems. His contributions continue to shape the future of medicine.